Check Out 3 Real Estate Stocks With Over 6% Dividend Yields From Wall Street’s Most Accurate Analysts – Medical Properties Trust (NYSE:MPW), Boston Props (NYSE:BXP)

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout. If you’re interested in these types of stocks, you’ll be glad to know that Benzinga has compiled the latest analyst ratings for high-yield dividend stocks in the real estate sector.

One such stock is Medical Properties Trust, Inc. (MPW). This company has a dividend yield of 17.96%. JP Morgan analyst Michael Lapides maintained an Underweight rating and cut the price target from $8 to $5 on November 29, 2023. Lapides has an accuracy rate of 60%. Raymond James analyst Jonathan Hughes downgraded the stock from Strong Buy to Underperform on August 11, 2023, and has an accuracy rate of 64%. In recent news, Medical Properties Trust reported quarterly revenues of $306.6 million on October 26, which fell short of the consensus estimate of $341.8 million.

Another high-yielding stock in the real estate sector is Boston Properties, Inc. (BXP), with a dividend yield of 6.88%. BMO Capital analyst John Kim maintained an Outperform rating and raised the price target from $75 to $80 on September 8, 2023. Kim has an accuracy rate of 64%. JP Morgan analyst Anthony Paolone maintained an Underweight rating and increased the price target from $62 to $66 on September 5, 2023. Paolone has an accuracy rate of 70%. In recent news, Boston Properties signed a deal with Norges Bank Investment Management to divest its 45% stake in two life sciences development properties at Kendall Square, Cambridge (Massachusetts) for a gross value of around $1.66 billion.

Lastly, National Health Investors, Inc. (NHI) is another high-yielding stock in the real estate sector, with a dividend yield of 6.61%. Wells Fargo analyst Todd Stender maintained an Equal-Weight rating and raised the price target from $54 to $55 on November 27, 2023. Stender has an accuracy rate of 71%. Jefferies analyst Joe Dickstein initiated coverage on the stock with a Hold rating and a price target of $52 on September 20, 2023. Dickstein has an accuracy rate of 64%. In recent news, National Health Investors posted upbeat sales for the third quarter.

These high-yield dividend stocks in the real estate sector offer investors an opportunity to earn passive income through regular dividend payments. However, it’s important to note that dividend yields can fluctuate based on various factors, including the company’s financial performance and market conditions. Therefore, it’s crucial to conduct thorough research and analysis before making any investment decisions.

To stay updated on the latest analyst ratings for your favorite stocks, you can visit Benzinga’s Analyst Stock Ratings page. Here, you can sort through Benzinga’s extensive database of analyst ratings, including ratings by analyst accuracy. By staying informed about the insights of the most accurate Wall Street analysts, you can make more informed investment decisions.